Fibroblast growth factor receptor 3 is a negative regulator of bone growth - PubMed (original) (raw)

Fibroblast growth factor receptor 3 is a negative regulator of bone growth

C Deng et al. Cell. 1996.

Free article

Abstract

Endochondral ossification is a major mode of bone that occurs as chondrocytes undergo proliferation, hypertrophy, cell death, and osteoblastic replacement. We have identified a role for fibroblast growth factor receptor 3 (FGFR-3) in this process by disrupting the murine Fgfr-3 gene to produce severe and progressive bone dysplasia with enhanced and prolonged endochondral bone growth. This growth is accompanied by expansion of proliferating and hypertrophic chondrocytes within the cartilaginous growth plate. Thus, FGFR-3 appears to regulate endochondral ossification by an essentially negative mechanism, limiting rather than promoting osteogenesis. In light of these mouse results, certain human disorders, such as achondroplasia, can be interpreted as gain-of-function mutations that activate the fundamentally negative growth control exerted by the FGFR-3 kinase.

PubMed Disclaimer

Similar articles

• A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors.
  Li C, Chen L, Iwata T, Kitagawa M, Fu XY, Deng CX. Li C, et al. Hum Mol Genet. 1999 Jan;8(1):35-44. doi: 10.1093/hmg/8.1.35. Hum Mol Genet. 1999. PMID: 9887329
• Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice.
  Segev O, Chumakov I, Nevo Z, Givol D, Madar-Shapiro L, Sheinin Y, Weinreb M, Yayon A. Segev O, et al. Hum Mol Genet. 2000 Jan 22;9(2):249-58. doi: 10.1093/hmg/9.2.249. Hum Mol Genet. 2000. PMID: 10607835
• Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains.
  Wang Q, Green RP, Zhao G, Ornitz DM. Wang Q, et al. Development. 2001 Oct;128(19):3867-76. doi: 10.1242/dev.128.19.3867. Development. 2001. PMID: 11585811
• Recent research on the growth plate: Advances in fibroblast growth factor signaling in growth plate development and disorders.
  Xie Y, Zhou S, Chen H, Du X, Chen L. Xie Y, et al. J Mol Endocrinol. 2014 Aug;53(1):T11-34. doi: 10.1530/JME-14-0012. J Mol Endocrinol. 2014. PMID: 25114206 Review.
• Mouse models orthologous to FGFR3-related skeletal dysplasias.
  Brodie SG, Deng CX. Brodie SG, et al. Pediatr Pathol Mol Med. 2003 Jan-Feb;22(1):87-103. doi: 10.1080/pdp.22.1.87.103. Pediatr Pathol Mol Med. 2003. PMID: 12687892 Review.

Cited by

• MPSI Manifestations and Treatment Outcome: Skeletal Focus.
  De Ponti G, Donsante S, Frigeni M, Pievani A, Corsi A, Bernardo ME, Riminucci M, Serafini M. De Ponti G, et al. Int J Mol Sci. 2022 Sep 22;23(19):11168. doi: 10.3390/ijms231911168. Int J Mol Sci. 2022. PMID: 36232472 Free PMC article. Review.
• Fasciculation and guidance of spinal motor axons in the absence of FGFR2 signaling.
  Huettl RE, Haehl T, Huber AB. Huettl RE, et al. PLoS One. 2012;7(7):e41095. doi: 10.1371/journal.pone.0041095. Epub 2012 Jul 17. PLoS One. 2012. PMID: 22815929 Free PMC article.
• A role for fibroblast growth factor signaling in the lobuloalveolar development of the mammary gland.
  Jackson D, Bresnick J, Dickson C. Jackson D, et al. J Mammary Gland Biol Neoplasia. 1997 Oct;2(4):385-92. doi: 10.1023/a:1026351414004. J Mammary Gland Biol Neoplasia. 1997. PMID: 10935026 Review.
• Activated FGFR3 suppresses bone regeneration and bone mineralization in an ovariectomized mouse model.
  Kawashima I, Matsushita M, Mishima K, Kamiya Y, Osawa Y, Ohkawara B, Ohno K, Kitoh H, Imagama S. Kawashima I, et al. BMC Musculoskelet Disord. 2023 Mar 16;24(1):200. doi: 10.1186/s12891-023-06318-9. BMC Musculoskelet Disord. 2023. PMID: 36927417 Free PMC article.
• Generation and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene.
  Yun J, Schöneberg T, Liu J, Schulz A, Ecelbarger CA, Promeneur D, Nielsen S, Sheng H, Grinberg A, Deng C, Wess J. Yun J, et al. J Clin Invest. 2000 Dec;106(11):1361-71. doi: 10.1172/JCI9154. J Clin Invest. 2000. PMID: 11104789 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • BioCyc
  • Gene Ontology
  • GlyGen glycoinformatics resource
  • Mouse Genome Informatics (MGI)

• Research Materials

  • Cellosaurus - a cell line knowledge resource